

The following products are regulated as Fractionated Plasma Products: Fractionated Plasma Products With Supporting Documents Albumin Alpha-1 Proteinase Inhibitor Antihemophilic Factor (Recombinant) Antihemophilic Factor (Recombinant), Glycopegylated-Exei Antihemophilic Factor (Recombinant), Pegylated-Aucl Antihemophilic Factor/von Willebrand Factor Complex Anti-Inhibitor Coagulant Complex Antithrombin (Recombinant) Antithrombin III (Human) C1 Esterase Inhibitor Coagulation Factors Coagulation Factor VIIa (Recombinant) - JNCW Coagulation Factor XA (Recombinant), Inactivated-ZHZO Corifact Fibrin Fibrinogen Immune Globulins Immune Globulin Subcutaneous, Human-DIRA Immune Globulin Subcutaneous, Human-KTHM, 10% Solution Immune Globulin Subcutaneous, Human-STWK Immune Globulin Subcutaneous (Human) Plasminogen, Human-TVMH Pooled Plasma (Human), Solvent/Detergent Treated Profilnine SD - Factor IX Complex Prothrombin Complex Concentrate, Human-LANS Kcentra (Prothrombin Complex Concentrate, Human) Protein C Concentrate Thrombin von Willebrand Factor (Recombinant)
What's New: Vaccines, Blood and Biologics
|13th Jan, 2026
|FDA
What's New: Vaccines, Blood and Biologics
|13th Jan, 2026
|FDA
What's New: Vaccines, Blood and Biologics
|13th Jan, 2026
|FDA
What's New: Vaccines, Blood and Biologics
|13th Jan, 2026
|FDA
What's New: Vaccines, Blood and Biologics
|13th Jan, 2026
|FDA
What's New: Vaccines, Blood and Biologics
|13th Jan, 2026
|FDA
What's New: Vaccines, Blood and Biologics
|13th Jan, 2026
|FDA